Recognition and Referral: Best Practices for Managing Patients with GA

Patients with advanced dry age-related macular degeneration can present with geographic atrophy (GA), a disease that is progressive and increases with age. Although there is no treatment approved by the FDA that halts or reverses GA, a number of drugs in the pipeline are designed to address GA progression, hoping to succeed where previous drug candidates failed. This series of regional, interactive, virtual symposia are designed to educate eye care providers on the importance of diagnosis and potential treatment options so they may plan accordingly for the best possible care of patients with GA.

This educational activity is designed for optometrists and general ophthalmologists.